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A PROGRAM FOR HOMELESS PERSONS
D.P. Goeman, RDNS Institute, Melbourne, Victoria, 
Australia
A large community health care organisation expanded 
their community-based assertive outreach Homeless Persons 
Program (HPP) to address a significant level of unmet health 
care need among people experiencing homelessness in a 
south-eastern region of Victoria despite the presence of well 
established homeless and healthcare services.
Evaluation of HPP program showed that the majority of 
assisted clients were successfully referred to at least three 
services. Key to clients accessing the services was the strong 
advocacy provided by the HPP nurse. This program has 
also helped establish various initiatives to improve clients’ 
social inclusion. The HPP model has positively impacted 
on clients’ lives and improved their capacity to engage 
with health and welfare services. This engagement has led 
to an increased sense of self-belief, resilience and improved 
social connections which have helped in reclaiming aspects 
of their lives.
SESSION 3390 (SYMPOSIUM)
ENHANCING THE INFORMED CONSENT PROCESS 
IN CLINICAL DEMENTIA RESEARCH
Chair: J. Haberstroh, Goethe University Frankfurt, 
Frankfurt am Main, DEUTSCHLAND, Germany
Co-Chair: J. Vollmann, Ruhr University Bochum, Bochum, 
Germany
Discussant: J. Moye, VA Medical Center, Jamaica Plain, 
Massachusetts
The high number of people suffering from dementia will 
significantly increase in European countries and elsewhere 
in the coming decades. No treatments are currently avail-
able that can reverse or even halt the neurodegenerative 
process, and dementia is a considerable burden on patients 
and caregivers, as well as on societies as a whole. For this 
reason, there is a substantial need for further medical demen-
tia research. People with dementia have the right to decide 
whether or not they want to participate in clinical research 
and to give their free, prior and informed consent. However, 
as dementia progresses, they can lose their ability to give 
informed consent to complex medical research because of an 
increasing loss of cognitive functions. At first sight, it seems 
ethically problematic to involve dementia patients in research, 
as people with impaired mental capacity must be protected 
against the risks of research participation. Furthermore, 
in contrast to informed consent to medical treatment, an 
individual benefit from participation in research can rarely 
be taken for granted. However, people with dementia also 
have a right to benefit from medical research in particular, 
so their categorical exclusion would appear to be ethically 
problematic too. High standards for the informed consent 
process and a thorough assessment of mental capacity are 
therefore important for the protection of research partici-
pants. In this Symposium, the international, interdiscipli-
nary ENSURE project will be presented. This project aims to 
contribute towards achieving an adequate balance between 
autonomy and the protection of dementia patients in clinical 
research.
ENSURE PROJECT: SUPPORTED DECISION-MAKING 
AND CAPACITY ASSESSMENT IN CLINICAL 
DEMENTIA RESEARCH
J. Haberstroh, F. Oswald, J. Pantel, Frankfurt Forum for 
Interdisciplinary Ageing Research, Goethe University 
Frankfurt, Frankfurt am Main, DEUTSCHLAND, Germany
This talk opens the symposium “Enhancing the Informed 
Consent Process in Clinical Dementia Research” and gives 
an overview of the project “Enhancing the Informed Consent 
Process: Supported decision-making and capacity assessment 
in clinical dementia research” (ENSURE). ENSURE aims to 
provide interdisciplinary recommendations to support the 
development of an action model of an informed consent 
process in clinical dementia research that a) enhances the 
capacity to consent of people with dementia, b) improves 
the assessment of decision-making capacity, c) protects those 
who do not have the capacity to consent, and d) guarantees 
the ethically justified inclusion of research subjects in clinical 
dementia research. To achieve this, four international pro-
ject partners cooperate on four interdisciplinary interlinked 
subprojects to be conducted in three successive phases. The 
disciplines involved are gerontology, ethics and law. In the 
symposium, the project partners will present the results of 
the first project phase of three of the subprojects.
OPPORTUNITIES AND RISKS OF SUPPORTED 
DECISION-MAKING IN DEMENTIA RESEARCH. AN 
ETHICAL ANALYSIS
J. Vollmann, J. Gather, M. Scholten, Ruhr University 
Bochum, Bochum, Germany
According to the interpretation of the Committee on the 
Rights of People with Disabilities (the Committee), article 12 
of the United Nations Convention on the Rights of People 
with Disabilities (CRPD) represents a radical departure from 
the widely accepted functional approach to assessing com-
petence, along with acknowledged procedures of substitute 
decision-making, in favor of a new paradigm of supported 
decision-making (SDM). Although sharing the Committee’s 
concerns about the discrimination of mentally disabled peo-
ple and welcoming the development of new measures for the 
enhancement of decision-making capacity, we have several 
reservations regarding the Committee’s interpretation. Our 
main worry is that the SDM model runs the risk of failing 
to distinguish between substitute and supported decision-
making. We therefore recommend a more limited and case-
specific application of SDM with a clear and transparent idea 
of the individual competence of patients involved in clinical 
dementia research.
ETHICAL FRAMEWORK OF INFORMED CONSENT 
AND DECISION-MAKING IN DEMENTIA RESEARCH
A. Carvalho, P. Hernández-Marrero, Instituto de Bioética, 
Universidade Católica Portuguesa, Porto, Portugal
Impaired decision-making capacity is a symptomatic 
feature in a number of neurodegenerative diseases, but the 
nature of these decision-making deficits depends on the par-
ticular disease. The level of impairment that renders a patient 
unable to make valid decisions should ideally reflect a societal 
judgment about the appropriate balance between respect-
ing the patient’s autonomy and protecting the patient from 
the potentially negative consequences of such a decision. 
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Although many types of decision-making exist, studies of 
decision-making in patients with neurodegenerative diseases 
generally use two decision-making paradigms; decision-mak-
ing under ambiguity and decision-making under risk. The 
main objective of this study is to determine the issues that 
should be taken into account during the informed consent 
process. This study encompasses two intertwined phases. The 
results will be integrated into an in-depth normative analysis 
of the conceptual and ethical issues raised by the informed 
consent process in clinical dementia research.
GERONTOLOGICAL DEMANDS AND ACTUAL 
CONDITIONS OF INFORMED CONSENT 
PROCEDURES IN DEMENTIA RESEARCH
M. Knebel, T. Wied, V. Tesky, Goethe University Frankfurt, 
Frankfurt am Main, Germany
In phase 1, the subproject Gerontology aims to identify 
the country-specific demands and actual conditions gov-
erning informed consent procedures in clinical dementia 
research in the participating countries. About 90 people with 
early stage dementia, and 90 caregivers/legal guardians (all 
involved in clinical dementia research) will be included. For 
the recruitment of potential subjects, we contact dementia 
researchers in Germany, Spain, and Portugal and ask them 
to share our online-study with their study participants. Semi-
structured online-interviews are conducted over a period of 
6  months. Participants are interviewed in order to gather 
information on existing informed consent conditions in clini-
cal dementia research. Furthermore, participants are asked to 
formulate and rate their needs, whereby the emphasis lays on 
the assessment of p-e fit indices in the domains of spatial and 
social needs versus existing conditions. Phase 1 will be fin-
ished in June 2017. The results of phase 1 will be presented.
SESSION 3340 (SYMPOSIUM)
TOWARD THE DEVELOPMENT OF A PERSON-
CENTERED INDEX OF AGING WELL IN CANADA 
AND MEXICO
Chair: E. Belanger, Brown University, Providence, Rhode 
Island
Co-Chair: U. Perez-Zepeda, Instituto Nacional de Geriatria
Discussant: M. Zunzunegui, Universite de Montreal, 
Montreal, Quebec, Canada
Despite a growing interest in successful aging among 
gerontologists, there remains a lack of consensus about the 
definition of this concept. The most common definition was 
proposed by Rowe & Kahn (1997): “a low probability of 
disease and disease-related disability, high cognitive and 
physical functional capacity, and active engagement with 
life” (p.  433). This appears unrealistic for the majority of 
older adults with no more than 11.9% percent of Americans, 
and a mean of 8.5% of older adults across European coun-
tries being free from major chronic diseases, physical dis-
ability, cognitive impairment, and participating in social 
and productive activities. When asked, the perspective of 
older adults themselves is broader, less medical, and more 
positive than those of the aforementioned researchers, and 
not dependent upon absence of disability or chronic illness. 
Literature reviews of lay perspectives confirm the importance 
of psychosocial components such as life satisfaction and 
self-mastery. This symposium includes three presentations as 
well as a thorough introduction about different models of 
successful and positive aging, and their prevalence and limi-
tations. The first presentation is a qualitative description of 
older adults’ perceptions of aging well in Canada. The sec-
ond concerns the development of a person-centered index 
of aging well and description of its distribution in Canada 
and Mexico, while the last addresses the individual and 
structural determinants of aging well from the perspective of 
older adults. Developing comprehensive measures of positive 
aging processes is important for health promotion if we are 
to tackle outcomes that truly matter to older adults.
OLDER ADULTS’ LAY PERCEPTIONS OF AGING 
WELL: A QUALITATIVE STUDY IN CANADA
E. Belanger3, U. Perez-Zepeda2, R.C. Castrejon-Perez2, 
G. Moullec1, 1. University of Montreal, Montreal, Quebec, 
Canada, 2. Instituto Nacional de Geriatria, Mexico City, 
Mexico, 3. Brown University School of Public Health, 
Providence, Rhode Island
Literature reviews about lay perspectives on successful 
aging suggest additional psychosocial components to the bio-
medical definition proposed by Rowe and Khan (1997). The 
research question guiding this study was: What is the per-
spective of older adults on aging well in Canada? A descrip-
tive study was carried out, using inductive qualitative content 
analysis to explore the domains of aging well that Canadian 
older adults report on, as compared with existing litera-
ture on lay perspectives. A random sub-sample of 40 older 
adults was selected from the ongoing International Mobility 
in Aging Study at two Canadian sites (Saint-Hyacinthe and 
Kingston), using a stratified selection process to ensure a 
diversity of ages, genders and education levels. Forty semi-
structured qualitative interviews were carried out with par-
ticipants to explore their perspectives on aging well. The 
results confirm the importance of symptomatic health con-
ditions including pain, as well as psychosocial components, 
such as attitude toward aging.
DEVELOPMENT OF A PERSON-CENTERED INDEX 
OF AGING WELL IN CANADA AND MEXICO
R.C. Castrejon-Perez2, E. Belanger1,3, U. Perez-Zepeda2, 
M. Zunzunegui1,3, 1. University of Montreal, Montreal, 
Quebec, Canada, 2. Instituto Nacional de Geriatria, 
Mexico City, Mexico, 3. Public Health Research Institute 
(IRSPUM), Montreal, Quebec, Canada
Starting from the results of a qualitative study in Canada 
and existing literature in different contexts, an index captur-
ing most of the domains used in definitions of successful aging 
was constructed, with a particular focus on lay perspectives. 
The index was developed using data gathered in 2014 from 
663 Canadian participants in the International Mobility in 
Aging Study (IMIAS) and 15,698 Mexican participants in 
the Mexican Healthy Aging Study (MHAS). It was com-
puted as a continuous score (0 to 100)  containing health-
related components (ADL disability, mobility disability, pain, 
self-rated health, and cognitive function), and psychosocial 
components (mood, productive activities, social relations, 
life satisfaction, and self-mastery). Mean scores on aging 
well were 80 among Canadian older adults and 59 among 
Mexican participants. The detailed scores indicate aspects of 
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